new version V2017

insulin secretagogues - Meglitinides (glinides)

     

TrialStudied treatmentControl treatmentpatientsROBResultNCT

diabetes type 2

mitiglinide
Gaomitiglinidenateglinide - NCT00461617
Kumashiro, 2007mitiglinideon top insulin glargine -
Kaku, 2009mitiglinideplacebo (on top pioglitazone) -
nateglinide
Hanefeld, 1990nateglinideplacebo -
Goldberg, 1998repaglinideplacebo -
Horton, 2000nateglinideplacebo -
Jovanovic, 2000repaglinideplacebo -
Moses, 2001nateglinideplacebo -
Marre, 2002nateglinideplacebo Exploratory -
Saloranta, 2002nateglinideplacebo -
Bech, 2003repaglinideplacebo -
Mari, 2005nateglinideplacebo -
Ristic, 2006nateglinidegliclazide (add on MET) Exploratory -
Li, 2007nategliniderepaglinide -
Li, 2009nategliniderepaglinide -
repaglinide
Goldberg, 1998repaglinideplacebo Exploratory -
Moses, 1999repaglinidecontrol (add on MET) Exploratory -
Landgraf, 1999repaglinideglibenclamide -
Marbury, 1999repaglinideglibenclamide -
Wolffenbuttel, 1999repaglinideglibenclamide -
Chuang, 1999repaglinideplacebo -
Landin-Olsson, 1999repaglinideplacebo (on top bedtime NPH-insulin) -
Raskin, 2000repaglinideon top troglitazone -
Jovanovic, 2000repaglinideplacebo -
Madsbad, 2001repaglinideglipizide -
Raskin, 2001repaglinideon top pioglitazone -
Raskin, 2001repaglinideon top rosiglitazone -
Lund, 2007repaglinidemetformin -